Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 0 | 1,770 | 0 | 1,645 | 9,295 |
| Cost of Goods | N/A | 275 | N/A | 264 | 205 |
| Gross Profit | N/A | 1,495 | N/A | 1,381 | 9,090 |
| Operating Expenses | 12,423 | 12,518 | 10,889 | 12,325 | 12,192 |
| Operating Income | -12,423 | -10,748 | -10,889 | -10,680 | -2,897 |
| Other Income | 8 | 66 | 23 | 7 | 302 |
| Pre-tax Income | -12,415 | -10,682 | -10,866 | -10,673 | -2,595 |
| Income Tax | -381 | -295 | -591 | N/A | N/A |
| Net Income Continuous | -12,034 | -10,682 | -10,275 | -10,673 | -2,595 |
| Net Income Discontinuous | 954 | 390 | 931 | N/A | N/A |
| Net Income | $-11,080 | $-10,682 | $-9,344 | $-10,673 | $-2,595 |
| EPS Basic Total Ops | -251.92 | -237.93 | -209.94 | -293.91 | -69.98 |
| EPS Basic Continuous Ops | -265.92 | -238.10 | -223.93 | -287.44 | -70.22 |
| EPS Basic Discontinuous Ops | 14.00 | 14.00 | 14.00 | N/A | N/A |
| EPS Diluted Total Ops | -251.92 | -237.93 | -209.94 | -293.91 | -69.98 |
| EPS Diluted Continuous Ops | -265.92 | -238.10 | -223.93 | -287.44 | -70.22 |
| EPS Diluted Discontinuous Ops | 14.00 | 14.00 | 14.00 | N/A | N/A |
| EBITDA(a) | $-12,213 | $-10,527 | $-10,656 | $-10,412 | $-10,645 |